Moderna (MRNA) Reports Publication of Phase 1 Data for mRNA Vaccines Against Two Potential Pandemic Influenza Strains
Tweet Send to a Friend
Moderna, Inc., (NASDAQ: MRNA) today announced the publication of results from two Phase 1 clinical studies showing that mRNA vaccines ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
